Comparison of remimazolam-based and propofol-based total intravenous anesthesia on postoperative quality of recovery : A randomized non-inferiority trial
Copyright © 2022 Elsevier Inc. All rights reserved..
STUDY OBJECTIVE: The quality of recovery (QoR) of remimazolam-based and propofol-based total intravenous anesthesia was compared as measured by QoR-15 scores.
DESIGN: A prospective, double-blind, randomized controlled, non-inferiority trial.
SETTING: An operating room, a post-anesthesia care unit (PACU), and a hospital ward.
PATIENTS: Female patients (n = 140; 20-65 years) scheduled for open thyroidectomy were enrolled and randomly assigned to the remimazolam or propofol group.
INTERVENTIONS: The remimazolam group received continuous remimazolam infusions and effect-site target-controlled remifentanil infusions. The propofol group received effect-site target-controlled infusions of propofol and remifentanil.
MEASUREMENTS: The primary outcome was QoR-15 on postoperative day 1 (POD1). The mean difference between the groups was compared against a non-inferiority margin of -8. Secondary outcomes were QoR-15 on POD2, hemodynamic data, time to lose and recover consciousness, sedation score upon PACU admission, pain, and postoperative nausea and vomiting profiles at the PACU and ward. Group-time interaction effects in hemodynamic data and QoR-15 were analyzed using a linear mixed model.
MAIN RESULTS: The total QoR-15 score on POD1 in the remimazolam group was non-inferior to that in the propofol group (mean [SD] 111.2 [18.8] vs. 109.1 [18.9]; mean difference [95% CI] 2.1 [-4.2, 8.5]; p = 0.002 for non-inferiority). The QoR-15 score on POD2 was comparable between the groups, and no group-time interaction was observed. At the end of anesthesia, after extubation, and upon arrival at the PACU, mean arterial pressure was significantly higher in the remimazolam group. Remimazolam group was more sedated at the time of admission to PACU. Pain intensity and the requirement for analgesics were lower in the remimazolam group than in the propofol group.
CONCLUSIONS: Remimazolam-based total intravenous anesthesia provided a similar QoR to propofol. Remimazolam and propofol can be used interchangeably for general anesthesia in female patients undergoing thyroid surgery.
| Errataetall: |
CommentIn: J Clin Anesth. 2023 Feb;84:110977. - PMID 36401885 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:82 |
|---|---|
| Enthalten in: |
Journal of clinical anesthesia - 82(2022) vom: 01. Nov., Seite 110955 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Choi, Jeong Yeon [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 13.09.2022 Date Revised 03.04.2023 published: Print-Electronic CommentIn: J Clin Anesth. 2023 Feb;84:110977. - PMID 36401885 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jclinane.2022.110955 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM345471512 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM345471512 | ||
| 003 | DE-627 | ||
| 005 | 20231226025129.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jclinane.2022.110955 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1151.xml |
| 035 | |a (DE-627)NLM345471512 | ||
| 035 | |a (NLM)36029704 | ||
| 035 | |a (PII)S0952-8180(22)00313-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Choi, Jeong Yeon |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Comparison of remimazolam-based and propofol-based total intravenous anesthesia on postoperative quality of recovery |b A randomized non-inferiority trial |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.09.2022 | ||
| 500 | |a Date Revised 03.04.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: J Clin Anesth. 2023 Feb;84:110977. - PMID 36401885 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 Elsevier Inc. All rights reserved. | ||
| 520 | |a STUDY OBJECTIVE: The quality of recovery (QoR) of remimazolam-based and propofol-based total intravenous anesthesia was compared as measured by QoR-15 scores | ||
| 520 | |a DESIGN: A prospective, double-blind, randomized controlled, non-inferiority trial | ||
| 520 | |a SETTING: An operating room, a post-anesthesia care unit (PACU), and a hospital ward | ||
| 520 | |a PATIENTS: Female patients (n = 140; 20-65 years) scheduled for open thyroidectomy were enrolled and randomly assigned to the remimazolam or propofol group | ||
| 520 | |a INTERVENTIONS: The remimazolam group received continuous remimazolam infusions and effect-site target-controlled remifentanil infusions. The propofol group received effect-site target-controlled infusions of propofol and remifentanil | ||
| 520 | |a MEASUREMENTS: The primary outcome was QoR-15 on postoperative day 1 (POD1). The mean difference between the groups was compared against a non-inferiority margin of -8. Secondary outcomes were QoR-15 on POD2, hemodynamic data, time to lose and recover consciousness, sedation score upon PACU admission, pain, and postoperative nausea and vomiting profiles at the PACU and ward. Group-time interaction effects in hemodynamic data and QoR-15 were analyzed using a linear mixed model | ||
| 520 | |a MAIN RESULTS: The total QoR-15 score on POD1 in the remimazolam group was non-inferior to that in the propofol group (mean [SD] 111.2 [18.8] vs. 109.1 [18.9]; mean difference [95% CI] 2.1 [-4.2, 8.5]; p = 0.002 for non-inferiority). The QoR-15 score on POD2 was comparable between the groups, and no group-time interaction was observed. At the end of anesthesia, after extubation, and upon arrival at the PACU, mean arterial pressure was significantly higher in the remimazolam group. Remimazolam group was more sedated at the time of admission to PACU. Pain intensity and the requirement for analgesics were lower in the remimazolam group than in the propofol group | ||
| 520 | |a CONCLUSIONS: Remimazolam-based total intravenous anesthesia provided a similar QoR to propofol. Remimazolam and propofol can be used interchangeably for general anesthesia in female patients undergoing thyroid surgery | ||
| 650 | 4 | |a Equivalence Trial | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 4 | |a Anesthesia | |
| 650 | 4 | |a Female | |
| 650 | 4 | |a Propofol | |
| 650 | 4 | |a Quality of recovery | |
| 650 | 4 | |a Remimazolam | |
| 650 | 4 | |a Thyroid surgery | |
| 650 | 7 | |a Anesthetics, Intravenous |2 NLM | |
| 650 | 7 | |a Benzodiazepines |2 NLM | |
| 650 | 7 | |a 12794-10-4 |2 NLM | |
| 650 | 7 | |a remimazolam |2 NLM | |
| 650 | 7 | |a 7V4A8U16MB |2 NLM | |
| 650 | 7 | |a Remifentanil |2 NLM | |
| 650 | 7 | |a P10582JYYK |2 NLM | |
| 650 | 7 | |a Propofol |2 NLM | |
| 650 | 7 | |a YI7VU623SF |2 NLM | |
| 700 | 1 | |a Lee, Hye Sun |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Ji Young |e verfasserin |4 aut | |
| 700 | 1 | |a Han, Dong Woo |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Ju Yeon |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Min Jae |e verfasserin |4 aut | |
| 700 | 1 | |a Song, Young |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical anesthesia |d 1996 |g 82(2022) vom: 01. Nov., Seite 110955 |w (DE-627)NLM013003399 |x 1873-4529 |7 nnns |
| 773 | 1 | 8 | |g volume:82 |g year:2022 |g day:01 |g month:11 |g pages:110955 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jclinane.2022.110955 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 82 |j 2022 |b 01 |c 11 |h 110955 | ||